Sunday, May 29, 2011 1:53:22 AM
Thirdly the agreement specifies "during the five consecutive trading days immediately following the date the notice of our election to put shares" That's NOT the date the shares were issued but the date the notice was given. If the notice was given the 18th the five trading days would have been 19th, 20th, 21st, 22nd and 25th (the 23rd and 24th were the weekend and not trading days.
I KNOW AND I FRIGGIN MADE THAT CLEAR, but we do not know when that notice was given do we?.....
Firstly your calculation is wrong and wrong in such a way as to create a problem where none exists.
$100,000 / 1,179,245 = .0848 (not .984)
.0848/.8 = 10.6 (not 10.5)
You do realize that ":On October 15, 2010, the Company issued 1,179,245 shares of common stock for $100,000 ($0.084/share)" is derived from kblb's financials, not my math...........lol, ty i didn't think of fact checking Kim Thompson's math.
Secondly Yahoo charts gives the closing price on OCT 19th as 0.11 - but that's to the nearest cent so that could well be 0.106
So there was no discrepancy whatsoever!
I think it is quite obvious that kblb has already used all of the equity line of credit..........all those things kblb is issuing shares for services for, are supposed to be covered in the equity line of credit...........i.e. kblb got a calm seas credit card, 1 million dollar limit, dont gotta pay back for 2 years......yet was still issuing tens of millions of shares for cash/services/.
I cannot help but note that, as in several previous instances, you appear to make series of errors that all are unfavorable to KBLB. Cherry picking embellished with a few select errors, IMHO.
the piggyBac transposon is inherently incapable of removing a gene, it can only make additions. Without the use of ZFs the work wouldn't progress at all. I would suggest that perhaps the reason that you "aren't seeing things" is that you either are just not paying attention or are short sighted.
plz dont talk about entogenetics.......i really dont care, and know about their attempts etc...
Sometime in the Fall" would certainly be sometime in 2011! Yet again you are claiming a problem where none exists. Do you think non one else can use a calendar?
As usual vague and no link and not even any figures. Most of us are aware that Kim did not collect his salary for several years in order to reduce the financial pressure on the company. His salary is very typical of CEOs of biotechs at a similar stage of development. yet again you are pulling "problems" out of thin air.
your whole post is null and void.......you still have not read the financials and bash my dd based directly on financials......
kblb spent 1.2 million last year, of which only 150k ish was for research and development......i am not saying kblb's expenses for 2010 should only be 150k. I think 1.2 million is obscene.
Recent KBLB News
- Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations • GlobeNewswire Inc. • 05/26/2026 11:35:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:19 PM
- Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform • GlobeNewswire Inc. • 05/20/2026 11:35:00 AM
- Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB) • IH Market News • 05/18/2026 03:12:33 PM
- Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications • GlobeNewswire Inc. • 05/18/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 12:14:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:05 AM
- The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer • GlobeNewswire Inc. • 05/13/2026 01:05:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:30:47 PM
- Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up • GlobeNewswire Inc. • 05/11/2026 11:05:00 AM
- Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race • GlobeNewswire Inc. • 05/07/2026 01:05:00 PM
- Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output • GlobeNewswire Inc. • 05/04/2026 11:05:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
